Company intelligence / Profile preview

NOVI Health

Centre Singapore, Singapore, Singapore

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

NOVI Health has demonstrated clinical results in diabetes management, with its Novi Magnum program showing an average reduction in HbA1c by 1% and weight loss of nearly 6% over three months among participants. The company's integrated approach combines continuous glucose monitoring, medical care, dietary guidance, and behavioral coaching to improve outcomes in chronic metabolic diseases.

Therapeutic areas: GastroenterologyEndocrinologyCardiovascular
Modalities: Non-pharmacological therapy (behavioral and lifestyle interventions)Device (continuous glucose monitoring technology)
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on NOVI Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NOVI Health.

Explore the full profile